Cargando…

Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis

BACKGROUND: Bladder cancer is the most common malignant tumor of the urinary system. Surgical resection and chemotherapy are the two mainstream treatments for bladder cancer. However, the outcomes are not satisfactory for patients with advanced bladder cancer. There is a need to further explore more...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wenlong, He, Xin, Yin, Haoli, Cao, Wenmin, Lin, Tingsheng, Chen, Wei, Diao, Wenli, Ding, Meng, Hu, Hao, Mo, Wenjing, Zhang, Qing, Guo, Hongqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284842/ https://www.ncbi.nlm.nih.gov/pubmed/35836291 http://dx.doi.org/10.1186/s13045-022-01312-5

Ejemplares similares

LysoPC and PAF Trigger Arachidonic Acid Release by Divergent Signaling Mechanisms in Monocytes
por: Oestvang, Janne, et al.
Publicado: (2011)

LysoPC acyltransferase/PC transacylase activities in plant plasma membrane and plasma membrane-associated endoplasmic reticulum
por: Larsson, Karin E, et al.
Publicado: (2007)

LysoPC-acyl C16:0 is associated with brown adipose tissue activity in men
por: Boon, Mariëtte R., et al.
Publicado: (2017)

Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC
por: Rindlisbacher, Barbara, et al.
Publicado: (2018)

Increasing Upstream Chromatin Long–Range Interactions May Favor Induction of Circular RNAs in LysoPC-Activated Human Aortic Endothelial Cells
por: Li, Angus, et al.
Publicado: (2019)

The effect of dietary lipid quality in early life on serum LysoPC(18:2) levels and their association with adult blood glucose levels in intrauterine growth restricted rats
por: Kodde, Andrea, et al.
Publicado: (2021)

circDHTKD1 promotes lymphatic metastasis of bladder cancer by upregulating CXCL5
por: Lu, Qun, et al.
Publicado: (2022)

The GPD program at COMPASS
por: Sznadjer, Pawel
Publicado: (2014)

The GPD program at COMPASS
por: Sandacz, Andrzej
Publicado: (2015)

GPD prospects at COMPASS
por: Burtin, Etienne
Publicado: (2009)

The GPD program at COMPASS
por: Sandacz, A
Publicado: (2009)

The GPD program at COMPASS
por: Sandacz, A
Publicado: (2011)

GPD program at COMPASS
por: D'Hose, N
Publicado: (2010)

GPD measurements at COMPASS
por: Lin, P J
Publicado: (2020)

Emerging Roles of PAR-1 and PAFR in Melanoma Metastasis
por: Melnikova, Vladislava O., et al.
Publicado: (2008)

Proposal for GPD studies at COMPASS
por: Burtin, E
Publicado: (2010)

Boosting Adaptive Immunity: A New Role for PAFR Antagonists
por: Koga, Marianna M., et al.
Publicado: (2016)

Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
por: Sohal, Sukhwinder Singh
Publicado: (2017)

Mass cytometry reveals immune atlas of urothelial carcinoma
por: Zhang, Qing, et al.
Publicado: (2022)

GPD study programme of COMPASS at CERN
por: Kouznetsov, O
Publicado: (2016)

Feasibility studies for GPD's measurement at COMPASS
por: Marroncle, J
Publicado: (2004)

Loss of PAFR prevents neuroinflammation and brain dysfunction after traumatic brain injury
por: Yin, Xiang-Jie, et al.
Publicado: (2017)

AprGPD: the apricot genomic and phenotypic database
por: Chen, Chen, et al.
Publicado: (2021)

Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer Treatment
por: Lin, Tingsheng, et al.
Publicado: (2020)

Non-bioenergetic roles of mitochondrial GPD2 promote tumor progression
por: Oh, Sehyun, et al.
Publicado: (2023)

PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancy
por: Zhao, Di, et al.
Publicado: (2023)

Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086
por: Cellai, C, et al.
Publicado: (2006)

Oxidized LDL Induces Alternative Macrophage Phenotype through Activation of CD36 and PAFR
por: Rios, Francisco J., et al.
Publicado: (2013)

PAFR selectively mediates radioresistance and irradiation-induced autophagy suppression in prostate cancer cells
por: Yao, Bing, et al.
Publicado: (2017)

O(2)-generating MnO(2) nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia
por: Lin, Tingsheng, et al.
Publicado: (2018)

GPD physics with polarized muon beams at COMPASS-II
por: Ferrero, Andrea
Publicado: (2012)

Lyso-glycosphingolipids: presence and consequences
por: van Eijk, Marco, et al.
Publicado: (2020)

Co-Stimulation of PAFR and CD36 Is Required for oxLDL-Induced Human Macrophages Activation
por: Rios, Francisco J. O., et al.
Publicado: (2012)

Temperature sensitive contact modes allosterically gate TRPV3
por: Burns, Daniel, et al.
Publicado: (2023)

Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers
por: Qin, Haixiang, et al.
Publicado: (2022)

"GPD (Generador de la planeacion didactica para docentes)"
por: Rodríguez Camarena, Patricia
Publicado: (2009)

MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma
por: Meng, Longxiyu, et al.
Publicado: (2023)

LYSO based precision timing calorimeters
por: Bornheim, A, et al.
Publicado: (2017)

Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma
por: Onuchic, Ana Claudia, et al.
Publicado: (2012)

Platelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR
por: Deng, Meng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gmaatd9l33b5ugb3eptkoebjn9